(2026). Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure. Neuropsychiatric Disease and Treatment.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure."
Neuropsychiatric Disease and Treatment 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Serum GDF-15 Levels in Pediatric ADHD: Associations with Symptom Severity and Stimulant Exposure."
Neuropsychiatric Disease and Treatment, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.